STRS Ohio’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,900
| Closed | -$810K | – | 2127 |
|
|
2022
Q3 | $810K | Buy |
+11,900
| New | +$656K | ﹤0.01% | 1024 |
|
|
2020
Q3 | – | Sell |
-9,812
| Closed | -$619K | – | 2314 |
|
|
2020
Q2 | $619K | Buy |
9,812
+2,512
| +34% | +$172K | ﹤0.01% | 1151 |
|
|
2020
Q1 | $372K | Sell |
7,300
-700
| -9% | -$46.9K | ﹤0.01% | 1354 |
|
|
2019
Q4 | $635K | Buy |
8,000
+2,000
| +33% | +$119K | ﹤0.01% | 1275 |
|
|
2019
Q3 | $291K | Sell |
6,000
-200
| -3% | -$10.4K | ﹤0.01% | 1544 |
|
|
2019
Q2 | $326K | Buy |
6,200
+2,300
| +59% | +$132K | ﹤0.01% | 1540 |
|
|
2019
Q1 | $206K | Buy |
3,900
+2,300
| +144% | +$113K | ﹤0.01% | 1666 |
|
|
2018
Q4 | $65K | Buy |
+1,600
| New | +$60K | ﹤0.01% | 1834 |
|
|
2017
Q3 | – | Sell |
-500
| Closed | -$13K | – | 1987 |
|
|
2017
Q2 | $13K | Hold |
500
| – | – | ﹤0.01% | 1896 |
|
|
2017
Q1 | $18K | Hold |
500
| – | – | ﹤0.01% | 1835 |
|
|
2016
Q4 | $7K | Hold |
500
| – | – | ﹤0.01% | 1893 |
|
|
2016
Q3 | $11K | Sell |
500
-4,200
| -89% | -$80.1K | ﹤0.01% | 1865 |
|
|
2016
Q2 | $77K | Buy |
4,700
+2,500
| +114% | +$50.4K | ﹤0.01% | 1716 |
|
|
2016
Q1 | $34K | Hold |
2,200
| – | – | ﹤0.01% | 1797 |
|
|
2015
Q4 | $71K | Hold |
2,200
| – | – | ﹤0.01% | 1744 |
|
|
2015
Q3 | $92K | Buy |
+2,200
| New | +$104K | ﹤0.01% | 1673 |
|
Other funds holding GBT
STRS Ohio's GBT Position: Q4 2022 in Review
STRS Ohio sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 11,900 shares — an estimated $810K sold.
STRS Ohio first reported a position in GBT in Q3 2015 and held it in 16 quarters. The position peaked at $810K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- STRS Ohio reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- STRS Ohio sold 11,900 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $810K.
- STRS Ohio first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
- STRS Ohio's Global Blood Therapeutics, Inc. position peaked at $810K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.